[1]
K. Siddiqui and B. Dubey, “Analytical Method Development and Validation of Ondansetron and Telmisartan in Tablet Dosage Form by RP-UPLC Method”, J. Drug Delivery Ther., vol. 12, no. 4-S, pp. 112–127, Aug. 2022, doi: 10.22270/jddt.v12i4-S.5548.